Insider Trading & Ownership of Eric Thomas Schmidt
-
Location
-
South San Francisco, CA
-
Summary
-
The estimated net worth of Eric Thomas Schmidt is at least $6,970,301 dollars as of 12 Jun 2023. Eric Thomas Schmidt is the Chief Financial Officer of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $6.4M. Eric Thomas Schmidt is the Director of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $573.8K.
-
Signature
-
/s/ Jack Anders, as Attorney-in-fact for Eric Schmidt
Follow Filing Activity
Follow Eric Thomas Schmidt and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Eric Thomas Schmidt has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,970,301.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Allogene Therapeutics, Inc. ($6,396,524).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Eric Thomas Schmidt
Insider Transactions Reported by Eric Thomas Schmidt:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.